Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68,652,138
-
Total 13F shares
-
2,209,512
-
Share change
-
+140,982
-
Total reported value
-
$14,469,013
-
Price per share
-
$6.52
-
Number of holders
-
9
-
Value change
-
+$1,044,013
-
Number of buys
-
8
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q4 2020
As of 31 Dec 2020,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,209,512 shares.
The largest 9 holders included
Altium Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, COMERICA BANK, Squarepoint Ops LLC, VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, Tower Research Capital LLC (TRC), and American Portfolios Advisors.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.